Joseph Caporusso, DPM
Foot & Ankle Surgery · McAllen, TXNPI 1528062213
Payments from drug & device makers
Across 777 payments — averaging $7669.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vertex$3.8M
- Tris Pharma Inc$695K
- Biotissue Holdings Inc.$491K
- Organogenesis Inc.$357K
- Endo Pharmaceuticals Inc.$186K
- GSK$172K
- plus $246K from 24 others
Across 57 payments — averaging $4799.35 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Integra Lifesciences Corporation$178K
- Polarityte, Inc.$89K
- Biotissue Holdings Inc.$6K
- Regeneron$1K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vertex | 6 | $3,812,763 |
| Tris Pharma Inc | 15 | $694,607 |
| Biotissue Holdings Inc. | 97 | $490,680 |
| Organogenesis Inc. | 450 | $356,734 |
| Endo Pharmaceuticals Inc. | 36 | $185,642 |
| GSK | 60 | $172,496 |
| Ipsen Innovation | 23 | $138,891 |
| Genentech, Inc. | 9 | $26,931 |
| Globus Medical | 10 | $25,105 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 16 | $21,249 |
| Convatec Inc. | 1 | $19,600 |
| Bristol Myers Squibb | 2 | $10,132 |
| Mylan Specialty L.p. | 5 | $1,399 |
| Endo USA, Inc. | 4 | $837 |
| Amgen | 8 | $423 |
| GE HealthCare | 1 | $245 |
| AbbVie(2 entities) | 3 | $235 |
| Smith+Nephew | 3 | $231 |
| Medline Industries LP | 2 | $182 |
| Melinta Therapeutics, LLC | 4 | $162 |
| Polarityte, Inc. | 2 | $150 |
| GRT US Holding, Inc. | 2 | $132 |
| Averitas Pharma Inc. | 1 | $117 |
| Paratek Pharmaceuticals, Inc. | 2 | $110 |
| Aroa Biosurgery Incorporated | 6 | $54 |
| Osiris Therapeutics Inc. | 2 | $42 |
| Amniox Medical, Inc. | 3 | $42 |
| Hydrofera LLC | 2 | $35 |
| Kerecis Limited | 1 | $16 |
| Sebela Pharmaceuticals Inc. | 1 | $16 |
How this compares
$5,959,259 in reported general payments places this provider in the 95th percentile of 684 foot & ankle surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other foot & ankle surgery in McAllen
- Richard PollakSan Antonio$6.1M
- Mark DaltonAustin$4.1M
- William McGarveyKaty$3.5M
- Eugene CurryDallas$3.1M
- Chad HowzeSan Antonio$2.4M
- Graham HamiltonEdinburg$2.1M
- Kevin VarnerHouston$1.1M
- Paul KimDallas$972K
- Mark RobsonAustin$957K
- Sherman NaglerHouston$602K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.